The University of Queensland

Developing a new type of drug for inflammatory lung disease (2023–2025)

Grant type:

NHMRC Development Grant

Researchers:

• 

  Professor David Fairlie

  NHMRC Leadership Fellow and Group L
  

  Institute for Molecular Bioscience

Funded by:

National Health and Medical Research Council